Physician profile
Robert Chvala
NPI 1609814094
$611.62
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $24.60 · 2021: $70.24 · 2022: $28.45 · 2023: $87.46 · 2024: $37.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $208.75 | 2019-2024 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $166.79 | 2019 | |
| Fresenius USA Marketing, INC. | $77.19 | 2019-2023 | Velphoro |
| Vifor Pharma, INC. | $47.94 | 2019-2023 | Veltassa |
| Boston Scientific Corporation | $27.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2023 | |
| Ardelyx, INC. | $18.77 | 2024 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.90 | 2023 | Jardiance |
| Amgen INC. | $14.89 | 2019 | |
| Akebia Therapeutics INC | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chvala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.